For example, in the STEP 1 trial , patients taking semaglutide lost an average of 14.9% of their body weight over 68 weeks , compared with just 2.4% in the placebo group (NEJM study)
[DOI] [PMC free article] [PubMed] [Google Scholar] 122.Kieliszek M
This total represents a year-over-year increase of 107%, and includes expenditures on both obesity- and Type 2 diabetes-indicated GLP-1s for patients with an obesity diagnosis
Glucose itself does not seem to directly modulate the catalytic activity of DPP-4, as shown in vitro , by incubating the enzyme with high concentrations of glucose ( in vitro , although, interestingly, not in macrovascular (human aortic) endothelial cells ( On the other hand, T2DM is often associated with increased body mass index (BMI), and other studies have suggested that levels of plasma DPP-4 activity actually correlate better with clinical parameters of obesity rather than of T2DM and glucose per se
At The PIP Rx, we are here to partner with you in aging well, recovering smarter, and feeling strong for the long term.